Biosynth

Explore our new comprehensive guide to CPP selection.  If you are looking for the right CPP to optimize your research, Biosynth's latest white paper can help. This guide takes you through the key considerations of the cargo properties, target cell type, and the desired intracellular localization, to give you the knowledge for your optimal CPP choice. https://lnkd.in/e4X9JVpZ No matter what your requirements are, we have a vast catalog of CPPs and custom options ready for your project today. https://lnkd.in/eawkrBfq #CPP #CellPenetratingPeptides #CustomSynthesis #Biosynth #PeptideModifications 

From signal amplification to precise analyte recognition, enzymes are the biological tools behind many of today’s most effective diagnostic assays. In Part 2 of our blog series, we dive into how enzymes are driving innovation in biomarker detection—bringing reliability, specificity, and versatility to the forefront of diagnostic science. Read the full blog here https://lnkd.in/e9-3eARV At Biosynth, we offer a broad portfolio of high-specificity enzymes for signal amplification and analyte detection—plus custom enzyme services tailored to your unique research and diagnostic challenges. Find out more on our website https://lnkd.in/eqcmJH52 #Diagnostics #Enzymes #Biomarkers #LifeSciences #ELISA #Biosensors #Biotech #phospholipaseD #HRP #alkalinephosphatase #galactosidase 

Biosynth are delighted to be exhibiting at Drug Discovery Chemistry 2025 in San Diego, Booth 604. We offer a comprehensive range of solutions to support every stage of drug discovery and development —from early-stage route scouting, custom synthesis, and GMP manufacturing to bulk reagent supply for the life sciences sector. We understand the complexities of drug discovery and are committed to providing quality, reliability, and scientific expertise. Visit us to learn how we can support your research with tailored solutions to meet your specific needs. 🔬 Booth 604 📅 April 14–17, 2025 📍 San Diego, CA Our experts Stefan Soderman, PhD and Mary Engels are looking forward to meeting you! #DDC2025 #DrugDiscovery #LifeSciences #PharmaInnovation

Sourcing disease state serum and plasma is complex, time-consuming, and often unavailable—creating challenges for diagnostic assay development. That’s why Biosynth offers human hybrid IgM monoclonal antibodies as a reliable alternative to IgM plasma. These novel alternatives offer: Lot-to-lot consistency  High specificity  ISO13485-certified production  A reliable source Inquire about Biosynth’s human hybrid IgM monoclonal antibodies today https://lnkd.in/emXx4MQH   Learn more about the role of disease state matrices, the limitations of IgM plasma, and Biosynth’s hybrid IgM antibody solution in our blog https://lnkd.in/e-uMzWHF #diagnostics #assaydevelopment #plasma #serum #diseasestateplasma #antibodies #controls

Diagnostic industries rely on a continuous source of antibody-rich plasma for the manufacture of positive controls and calibrators, as well as for purification purposes. Biosynth provides bulk disease-state plasma and serum to in vitro diagnostic manufacturers worldwide. We specialize in infectious diseases, autoimmune and allergy disorders, serum proteins, and myeloma plasma. Whether you are developing a new diagnostic assay or on the cusp of discovering a novel biomarker, Biosynth’s biospecimens, serum, plasma, and blood can help https://lnkd.in/esy-e4JE #diagnostics #IVD #plasma #serum #biospecimens #controls #calibrators #assaydevelopment #biomarkers #diseasestate

Enzymes are powerful biomarkers and diagnostic tools driving the rapid rise in sensitive diagnostic assays. In the first of our two-part blog series, we will explore how enzymes are key biomarkers for illnesses such as cardiac disorders, cancer and bone, liver, and neurodegenerative diseases. Read the full blog here https://lnkd.in/e5DgSBZB At Biosynth, our extensive enzyme portfolio is designed to support your research and diagnostic development needs. Whether you're looking for high-specificity enzymes for analyte detection or signal amplification, we’ve got you covered. Need a custom enzyme? Our enzyme services include:  Enzyme identification  Process development  ISO 9001:2015-compliant manufacturing  Scale-up from milligrams to multi-kilograms Find out more on our website https://lnkd.in/eqcmJH52 #Diagnostics #Enzymes #Biomarkers #LifeSciences #ELISA #Biosensors #Biotech

A new disease threat watch list for pathogens this morning published in the UK (https://lnkd.in/eaQjDD8r). Biosynth has an extensive range of reagents for diagnostics (including antigens, antibodies and plasma) as well as development services and material supply for those developing vaccines and treatment within life sciences. Developing a full disease library to address the needs of our customers means we are constantly updating both diseases and strains as they are reported. Here is the full list of diseases on the UK watch list - Adenovirus, Lassa fever, Norovirus, Mers, Ebola (and similar viruses, such as Marburg), Flaviviridae (which includes dengue, Zika and hepatitis C), Hantavirus, Crimean-Congo haemorrhagic fever, Flu (non-seasonal, including avian), Nipah virus, Oropouche, Rift Valley fever, acute flaccid myelitis, Human metapneumovirus (HMPV), Mpox, Chikungunya, Anthrax, Q fever, Enterobacteriaceae (such as E. coli and Yersinia pestis), Tularaemia, Moraxellaceae (which cause lung, urine and bloodstream infections), Gonorrhoea, Staplylococcus, Group A and B Strep. #diagnostics #pathogens #biosynthdiagnostics

Day one of CACLP 2025! The Biosynth team is looking forward to connecting with you to discuss how we can support your diagnostic projects. Whether you're working on custom solutions or need raw materials for your diagnostic assays, we are here to help. We offer a wide a range of biological reagents, research kits, and research area-specific products including those for emerging infectious diseases, veterinary science, cancer, neurology, and more. Visit our diagnostic reagents for IVD webpage to discover our full offering: https://lnkd.in/d4f2Zx4P 📍 Find us at Hall 4, Booth E0305 Stop by to meet Philip Noone. CDir, Dongjia(Davy) Lu, and Pragya Maheshwari, and discuss how our solutions can enhance your IVD projects. #CACLP2025 #IVD #Diagnostics

Custom peptide expertise for optimizing your CPP. Our expert team can provide unparalleled peptide synthesis and conjugation services, crafting precise molecules for your research. From standard sequences to tailored creations, we modify CPPs to your exact needs. Our seamless conjugation services expertly link your payload to a variety of CPPs, ensuring efficient delivery and optimal results. For a comprehensive guide to CPP selection, visit our blog. https://lnkd.in/e2bfpYAa Explore limitless possibilities with our custom peptide synthesis, diverse modifications, and flexible functionalization options, and contact us today. https://lnkd.in/dBc_HQFV #CustomSynthesis #Peptide #PeptideSynthesis #Biosynth #CPP #CellPenetratingPeptide

Synthetic enzyme substrates are revolutionizing the pharmaceutical industry, offering an alternative to traditional methods. Producing a measurable signal in the presence of specific bacteria, these have advantages over other methods including: • Specificity - target particular enzymes  • Speed - signals are detected quickly, usually without additional tests  • Economic viability - more cost-effective Read our most recent blog to delve into the different types of enzyme substrates and their implications for microbiology and clinical diagnostic applications. https://lnkd.in/e7ji4VC7 Biosynth have developed a range of innovative enzyme substrates over the years for applications in diagnostics, culture media, food and environmental testing.  To find out more about our diverse range of substrates, including chromogenic, fluorogenic and bioluminescent substrates, visit us today. https://lnkd.in/etifGfsX #EnzymeSubstrates #Microbiology #Diagnostics #BacterialDetection #Biosynth #Innovation